Search research articles
Contact Us
Filters
Showing results (11-20 of 119) with videos related to
Page
of 12
Sort By:
Virology
|
January 1, 1988
Induction of an antiviral state by interferon in the absence of elevated levels of 2,5-oligo(A) synthetase and eIF-2 kinase
J A Lewis
Clinical Pharmacology and Therapeutics
|
May 1, 1975
Deanol and methylphenidate in minimal brain dysfunction
J A Lewis, R Young
Statistics in Medicine
|
May 15, 1995
The case for cross-over trials in phase III
B Jones, J A Lewis
Journal of Clinical Pharmacology
|
January 1, 1992
Epanolol as a model for assessing patient preference in anti-anginal drug therapy
P Blake, J A Lewis
Brain Research Bulletin
|
November 1, 1992
A detergent-solubilized nicotinic acetylcholine receptor of Caenorhabditis elegans
J A Lewis, S Berberich
Developmental and Comparative Immunology
|
January 1, 1983
Bacteria-immune system interactions. XII. Effects of aging on Balb/c mice responsiveness to Salmonella typhimurium
R Kleinman, J A Lewis
Virology
|
March 1, 1984
Induction of an anti-viral response and 2',5'-oligo A synthetase by interferon in several thymidine kinase-deficient cell lines
J A Lewis, M Esteban
Virology
|
May 1, 1989
Interferon-induced expression of different genes is mediated by distinct regulatory pathways
B Shan, J A Lewis
Nucleic Acids Research
|
May 29, 2001
Control of directionality in integrase-mediated recombination: examination of recombination directionality factors (RDFs) including Xis and Cox proteins
J A Lewis, G F Hatfull
Aviation, Space, and Environmental Medicine
|
September 1, 1995
The feasibility of collecting in-flight EEG data from helicopter pilots
J A Caldwell, J A Lewis
Page
of 12
Search research articles
Search
Showing results (11-20 of 119) with videos related to
Sort By:
Page
of 12
Virology
|
January 1, 1988
Induction of an antiviral state by interferon in the absence of elevated levels of 2,5-oligo(A) synthetase and eIF-2 kinase
J A Lewis
Clinical Pharmacology and Therapeutics
|
May 1, 1975
Deanol and methylphenidate in minimal brain dysfunction
J A Lewis, R Young
Statistics in Medicine
|
May 15, 1995
The case for cross-over trials in phase III
B Jones, J A Lewis
Journal of Clinical Pharmacology
|
January 1, 1992
Epanolol as a model for assessing patient preference in anti-anginal drug therapy
P Blake, J A Lewis
Brain Research Bulletin
|
November 1, 1992
A detergent-solubilized nicotinic acetylcholine receptor of Caenorhabditis elegans
J A Lewis, S Berberich
Developmental and Comparative Immunology
|
January 1, 1983
Bacteria-immune system interactions. XII. Effects of aging on Balb/c mice responsiveness to Salmonella typhimurium
R Kleinman, J A Lewis
Virology
|
March 1, 1984
Induction of an anti-viral response and 2',5'-oligo A synthetase by interferon in several thymidine kinase-deficient cell lines
J A Lewis, M Esteban
Virology
|
May 1, 1989
Interferon-induced expression of different genes is mediated by distinct regulatory pathways
B Shan, J A Lewis
Nucleic Acids Research
|
May 29, 2001
Control of directionality in integrase-mediated recombination: examination of recombination directionality factors (RDFs) including Xis and Cox proteins
J A Lewis, G F Hatfull
Aviation, Space, and Environmental Medicine
|
September 1, 1995
The feasibility of collecting in-flight EEG data from helicopter pilots
J A Caldwell, J A Lewis
Page
of 12